Request Deal Involvement

Arboretum Ventures and Johnson & Johnson Innovation led a $78m Series D round in Orasis Pharmaceuticals.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

or

Principals

JOHNSON & JOHNSON INNOVATION - JJDC INC

bidder

JOHNSON & JOHNSON INNOVATION - JJDC INC

SBI (JAPAN) INNOVATION FUND

bidder

SBI (JAPAN) INNOVATION FUND

CATALIO CAPITAL MANAGEMENT

bidder

CATALIO CAPITAL MANAGEMENT

MAVERICK VENTURES

bidder

MAVERICK VENTURES

FREEPOINT CAPITAL GROUP

bidder

FREEPOINT CAPITAL GROUP

VISIONARY VENTURES

bidder

VISIONARY VENTURES

SEQUOIA CAPITAL

bidder

SEQUOIA CAPITAL

ORASIS PHARMACEUTICALS

target

ORASIS PHARMACEUTICALS

ARBORETUM VENTURES

bidder

ARBORETUM VENTURES

BLUESTEM CAPITAL

bidder

BLUESTEM CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Arboretum Ventures and Johnson & Johnson Innovation led a $78m Series D round in Orasis Pharmaceuticals.